{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T08:44:05Z","timestamp":1768639445592,"version":"3.49.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mdconsult.com","interventional.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.iccl.2014.03.001","type":"journal-article","created":{"date-parts":[[2014,6,28]],"date-time":"2014-06-28T03:00:27Z","timestamp":1403924427000},"page":"317-331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Implications of Kidney Disease in the Cardiac Patient"],"prefix":"10.1016","volume":"3","author":[{"given":"Roger","family":"Rear","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Meier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iccl.2014.03.001_bib1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archinte.164.6.659","article-title":"Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization","volume":"164","author":"Keith","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/ki.2008.694","article-title":"The message for world kidney day 2009: hypertension and kidney disease: a marriage that should be prevented","volume":"75","author":"Bakris","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.iccl.2014.03.001_bib3","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1161\/CIRCULATIONAHA.111.085290","article-title":"Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis","volume":"125","author":"Maioli","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2014.03.001_bib4","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.jacc.2007.11.072","article-title":"Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (treating to new targets) study","volume":"51","author":"Shepherd","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/heart.89.9.1003","article-title":"Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (grace)","volume":"89","author":"Santopinto","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.iccl.2014.03.001_bib6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2014.03.001_bib7","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1093\/eurheartj\/ehs274","article-title":"Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial","volume":"33","author":"Hohnloser","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2014.03.001_bib8","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1160\/TH11-10-0721","article-title":"Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin k antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics)","volume":"107","author":"Poli","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.iccl.2014.03.001_bib9","first-page":"1","article-title":"Hypertension awareness, treatment, and control\u2014continued disparities in adults: United States, 2005-2006","author":"Ostchega","year":"2008","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.iccl.2014.03.001_bib10","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1093\/eurheartj\/eht159","article-title":"Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980-2009","volume":"34","author":"Nichols","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2014.03.001_bib11","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1097\/HJH.0b013e32833ec377","article-title":"The progressive pathway of microalbuminuria: from early marker of renal damage to strong cardiovascular risk predictor","volume":"28","author":"Cerasola","year":"2010","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.iccl.2014.03.001_bib12","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ndt\/gfh813","article-title":"Chronic kidney disease as cause of cardiovascular morbidity and mortality","volume":"20","author":"Vanholder","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 87","key":"10.1016\/j.iccl.2014.03.001_bib13","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1046\/j.1523-1755.64.s87.5.x","article-title":"Chronic kidney disease and cardiovascular disease in the Medicare population","volume":"64","author":"Collins","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.iccl.2014.03.001_bib14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2369-14-62","article-title":"Renal dysfunction in STEMI-patients undergoing primary angioplasty: higher prevalence but equal prognostic impact in female patients; an observational cohort study from the Belgian STEMI Registry","volume":"14","author":"Gevaert","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.iccl.2014.03.001_bib15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000197562","article-title":"Phosphate\u2014the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review","volume":"27","author":"Kanbay","year":"2009","journal-title":"Blood Purif"},{"issue":"Suppl 111","key":"10.1016\/j.iccl.2014.03.001_bib16","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/ki.2008.516","article-title":"Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease","volume":"74","author":"Cachofeiro","year":"2008","journal-title":"Kidney Int Suppl"},{"issue":"Suppl 3","key":"10.1016\/j.iccl.2014.03.001_bib17","first-page":"S4","article-title":"Piecing together the evidence on anemia: the link between chronic kidney disease and cardiovascular disease","volume":"6","author":"McCullough","year":"2005","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib18","doi-asserted-by":"crossref","first-page":"I80","DOI":"10.1161\/01.HYP.13.5_Suppl.I80","article-title":"Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-Up Program Cooperative Group","volume":"13","author":"Shulman","year":"1989","journal-title":"Hypertension"},{"key":"10.1016\/j.iccl.2014.03.001_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2215\/CJN.00730805","article-title":"Kidney-heart interactions: epidemiology, pathogenesis, and treatment","volume":"1","author":"Berl","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.iccl.2014.03.001_bib20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.5935\/0101-2800.20120003","article-title":"Prospective study of 2151 patients with chronic kidney disease under conservative treatment with multidisciplinary care in the Vale do Paraiba, SP","volume":"34","author":"Luciano Ede","year":"2012","journal-title":"J\u00a0Bras Nefrol"},{"key":"10.1016\/j.iccl.2014.03.001_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2796.2009.02204.x","article-title":"Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the Swedeheart Register","volume":"268","author":"Szummer","year":"2010","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib22","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third universal definition of myocardial infarction","volume":"60","author":"Thygesen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib23","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/MCA.0000000000000046","article-title":"Interpreting cardiac troponin results from highly sensitive assays in patients with chronic kidney disease: acute coronary syndromes and beyond","volume":"24","author":"End","year":"2013","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.iccl.2014.03.001_bib24","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1681\/ASN.2004090765","article-title":"High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination","volume":"16","author":"Ohtake","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.iccl.2014.03.001_bib25","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/ndt\/16.7.1452","article-title":"Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis and New Cardiac Markers Evaluation (CHANCE) study","volume":"16","author":"Iliou","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.iccl.2014.03.001_bib26","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1253\/circj.71.1366","article-title":"Renal insufficiency is related to painless myocardial infarction","volume":"71","author":"Komukai","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.iccl.2014.03.001_bib27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.2004070610","article-title":"Association between chronic kidney disease and coronary artery calcification: the Dallas Heart Study","volume":"16","author":"Kramer","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.iccl.2014.03.001_bib28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000335066","article-title":"Association of mild to moderate kidney dysfunction with coronary artery calcification in patients with suspected coronary artery disease","volume":"120","author":"Cao","year":"2011","journal-title":"Cardiology"},{"key":"10.1016\/j.iccl.2014.03.001_bib29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2011.04.024","article-title":"Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) study","volume":"58","author":"Budoff","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.iccl.2014.03.001_bib30","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/ki.2010.70","article-title":"Coronary artery calcification and mortality in diabetic patients with proteinuria","volume":"77","author":"Chiu","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.iccl.2014.03.001_bib31","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/ki.2010.405","article-title":"Coronary artery calcification and cardiovascular mortality in predialysis patients","volume":"79","author":"Russo","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.iccl.2014.03.001_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/157340309788970342","article-title":"Coronary risk assessment and management options in chronic kidney disease patients prior to kidney transplantation","volume":"5","author":"Karthikeyan","year":"2009","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.iccl.2014.03.001_bib33","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.iccl.2014.03.001_bib34","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jacc.2010.02.068","article-title":"Aspirin is\u00a0beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial","volume":"56","author":"Jardine","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib35","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1751-7176.2007.tb00006.x","article-title":"Hypertension and coronary artery disease: a summary of the American Heart Association scientific statement","volume":"9","author":"Rosendorff","year":"2007","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.iccl.2014.03.001_bib36","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.iccl.2014.03.001_bib37","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib38","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2014.03.001_bib39","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0195-668X(03)00485-8","article-title":"Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)","volume":"24","author":"Moscucci","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2014.03.001_bib40","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.amjcard.2009.07.043","article-title":"Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease","volume":"104","author":"Sedlis","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib41","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.amjcard.2013.07.034","article-title":"Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial)","volume":"112","author":"Sedlis","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib42","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jcin.2009.05.002","article-title":"The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials","volume":"2","author":"Reed","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2014.03.001_bib43","doi-asserted-by":"crossref","first-page":"H491","DOI":"10.1152\/ajpheart.00721.2012","article-title":"Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease","volume":"304","author":"Hecker","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jacc.2013.04.105","volume":"63","author":"Leoncini","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib45","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijcard.2013.12.017","article-title":"Preventive effect of statin pretreatment on contrast-induced acute kidney injury in patients undergoing coronary angioplasty: propensity score analysis from a multicenter registry","volume":"171","author":"Hoshi","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib46","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.112.096370","article-title":"Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RENPRO trial (renal protection trial)","volume":"126","author":"Er","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2014.03.001_bib47","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jacc.2013.02.023","article-title":"Renoprotective effect of remote ischemic post-conditioning by intermittent balloon inflations in patients undergoing percutaneous coronary intervention","volume":"61","author":"Deftereos","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib48","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1681\/ASN.2010050553","article-title":"Preoperative proteinuria predicts adverse renal outcomes after coronary artery bypass grafting","volume":"22","author":"Huang","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.iccl.2014.03.001_bib49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/ajkd.2003.50026","article-title":"Chronic kidney disease as a risk factor for bleeding complications after coronary artery bypass surgery","volume":"41","author":"Winkelmayer","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.iccl.2014.03.001_bib50","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ahj.2013.02.012","article-title":"Comparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based population with chronic kidney disease","volume":"165","author":"Chang","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.iccl.2014.03.001_bib51","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJMoa1110717","article-title":"Comparative effectiveness of revascularization strategies","volume":"366","author":"Weintraub","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib52","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1681\/ASN.2012020122","article-title":"Off-pump versus on-pump coronary artery bypass grafting outcomes stratified by preoperative renal function","volume":"23","author":"Chawla","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.iccl.2014.03.001_bib53","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00000441-200304000-00010","article-title":"Valvular and perivalvular abnormalities in end-stage renal disease","volume":"325","author":"Umana","year":"2003","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.iccl.2014.03.001_bib54","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.iccl.2014.03.001_bib55","first-page":"1","article-title":"Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review","volume":"24","author":"Cerasola","year":"2011","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.iccl.2014.03.001_bib56","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/1753944708093846","article-title":"The left atrium, atrial fibrillation, and the risk of stroke in hypertensive patients with left ventricular hypertrophy","volume":"2","author":"Wachtell","year":"2008","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.iccl.2014.03.001_bib57","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ahj.2010.03.027","article-title":"Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC)","volume":"159","author":"Soliman","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.iccl.2014.03.001_bib58","first-page":"177","article-title":"The sensitivity of the method used to detect atrial fibrillation in population studies affects group-specific prevalence estimates: ethnic and regional distribution of atrial fibrillation in the regards study","volume":"19","author":"Prineas","year":"2009","journal-title":"J\u00a0Epidemiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib59","first-page":"617","article-title":"The epidemiology of atrial fibrillation in end-stage renal disease","volume":"26","author":"Korantzopoulos","year":"2013","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.iccl.2014.03.001_bib60","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1681\/ASN.2009101047","article-title":"Digoxin associates with mortality in ESRD","volume":"21","author":"Chan","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.iccl.2014.03.001_bib61","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ahj.2013.05.010","article-title":"Management of atrial fibrillation in chronic kidney disease: double trouble","volume":"166","author":"Nimmo","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.iccl.2014.03.001_bib62","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1540-8159.2012.03350.x","article-title":"Impact of impaired renal function and metabolic syndrome on the recurrence of atrial fibrillation after catheter ablation: a long term follow-up","volume":"35","author":"Berkowitsch","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib63","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.hrthm.2010.10.047","article-title":"Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up","volume":"8","author":"Naruse","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.iccl.2014.03.001_bib64","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/hrt.2010.200824","article-title":"Relationship between renal function and the risk of recurrent atrial fibrillation following catheter ablation","volume":"97","author":"Tokuda","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.iccl.2014.03.001_bib65","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.iccl.2014.03.001_bib66","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1160\/TH13-01-0054","article-title":"Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASC stroke stratification risk scores for atrial fibrillation?","volume":"109","author":"Roldan","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.iccl.2014.03.001_bib67","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCULATIONAHA.108.816082","article-title":"Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study","volume":"119","author":"Go","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2014.03.001_bib68","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.amjcard.2010.10.074","article-title":"Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation","volume":"107","author":"Nakagawa","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib69","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"Olesen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib70","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A\u00a0novel user-friendly score (has-bled) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.iccl.2014.03.001_bib71","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.ajkd.2010.05.023","article-title":"Warfarin dosing in patients with impaired kidney function","volume":"56","author":"Limdi","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.iccl.2014.03.001_bib72","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1681\/ASN.2009030319","article-title":"Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation","volume":"20","author":"Chan","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.iccl.2014.03.001_bib73","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.2215\/CJN.04550511","article-title":"Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation","volume":"6","author":"Winkelmayer","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.iccl.2014.03.001_bib74","first-page":"33","article-title":"Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin","volume":"2","author":"Lai","year":"2009","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.iccl.2014.03.001_bib75","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/ndt\/gfr341","article-title":"Coumarins and survival in incident dialysis patients","volume":"27","author":"Knoll","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.iccl.2014.03.001_bib76","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib77","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib78","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib79","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ejheart.2007.05.010","article-title":"Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction","volume":"9","author":"Damman","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.iccl.2014.03.001_bib80","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11936-008-0054-5","article-title":"The progressive cardiorenal syndrome in heart failure: Mechanisms and therapeutic insights","volume":"10","author":"Brown","year":"2008","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib81","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1388-9842(01)00174-X","article-title":"Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure","volume":"3","author":"Erdmann","year":"2001","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.iccl.2014.03.001_bib82","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cardfail.2008.11.003","article-title":"The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR\/XL Randomized Intervention Trial in Chronic HF (MERIT-HF)","volume":"15","author":"Ghali","year":"2009","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.iccl.2014.03.001_bib83","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.ki.5001835","article-title":"Beta blockers in the management of chronic kidney disease","volume":"70","author":"Bakris","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.iccl.2014.03.001_bib84","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/ki.2013.355","article-title":"Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation?","volume":"85","author":"Sarafidis","year":"2013","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.iccl.2014.03.001_bib85","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jacc.2013.10.050","article-title":"ACE inhibitor and angiotensin receptor blocker use and mortality in patients with chronic kidney disease","volume":"63","author":"Molnar","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib86","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0002-9149(92)91194-9","article-title":"Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study [Consensus] Trial)","volume":"70","author":"Ljungman","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib87","doi-asserted-by":"crossref","first-page":"40D","DOI":"10.1016\/0002-9149(90)90475-G","article-title":"Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the Consensus Trial). Consensus Trial Study Group","volume":"66","author":"Swedberg","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib88","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijcard.2011.12.056","article-title":"Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD treatment trial","volume":"167","author":"Bowling","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib89","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(09)61913-9","article-title":"Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial","volume":"374","author":"Konstam","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.iccl.2014.03.001_bib90","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib91","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib92","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.jacc.2012.07.048","article-title":"Influence of baseline and worsening renal function on efficacy of spironolactone in patients with severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study)","volume":"60","author":"Vardeny","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib93","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.iccl.2014.03.001_bib94","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.amjcard.2005.12.072","article-title":"Relation of loop diuretic dose to mortality in advanced heart failure","volume":"97","author":"Eshaghian","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib95","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0002-9343(82)90854-3","article-title":"Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia","volume":"72","author":"Wollam","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib96","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacc.2007.07.094","article-title":"Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure","volume":"51","author":"Tang","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib97","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01498-5","article-title":"The prognostic importance of anemia in patients with heart failure","volume":"114","author":"Kosiborod","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib98","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0735-1097(01)01470-X","article-title":"Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction","volume":"38","author":"Al-Ahmad","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib99","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7326\/0003-4819-153-1-201007060-00252","article-title":"Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease","volume":"153","author":"Palmer","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib100","doi-asserted-by":"crossref","first-page":"e43655","DOI":"10.1371\/journal.pone.0043655","article-title":"Hemoglobin targets for chronic kidney disease patients with anemia: a systematic review and meta-analysis","volume":"7","author":"Jing","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.iccl.2014.03.001_bib101","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1388-9842(01)00176-3","article-title":"The CARE-HF study (Cardiac Resynchronisation in Heart Failure study): rationale, design and end-points","volume":"3","author":"Cleland","year":"2001","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.iccl.2014.03.001_bib102","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cardfail.2008.03.009","article-title":"Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate","volume":"14","author":"Boerrigter","year":"2008","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.iccl.2014.03.001_bib103","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.amjcard.2006.11.055","article-title":"Anemia as a risk factor for kidney function decline in individuals with heart failure","volume":"99","author":"Bansal","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib104","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0025-6196(12)60103-7","article-title":"Venous complications after insertion of a transvenous pacemaker","volume":"67","author":"Spittell","year":"1992","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.iccl.2014.03.001_bib105","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0085-2538(15)50904-6","article-title":"Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators","volume":"68","author":"Herzog","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.iccl.2014.03.001_bib106","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10840-010-9484-6","article-title":"Implantable cardioverter defibrillators confer survival benefit in patients with renal insufficiency but not in dialysis-dependent patients","volume":"28","author":"Khan","year":"2010","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.iccl.2014.03.001_bib107","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1053\/j.ajkd.2011.02.376","article-title":"Sudden cardiac death in hemodialysis patients: an in-depth review","volume":"57","author":"Green","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.iccl.2014.03.001_bib108","unstructured":"U.S. Renal Data System. USRDS 2013 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. 2013. p. 1, 2. Available at: http:\/\/www.usrds.org\/atlas.aspx."},{"key":"10.1016\/j.iccl.2014.03.001_bib109","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD investigators","volume":"325","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib110","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.iccl.2014.03.001_bib111","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"Cardiac Resynchronization-Heart Failure Study I. The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib112","first-page":"1429","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (Consensus). The Consensus Trial Study Group","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib113","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: metoprolol CR\/XL randomised intervention trial in congestive heart failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.iccl.2014.03.001_bib114","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II):\u00a0a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.iccl.2014.03.001_bib115","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib116","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the Capricorn randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.iccl.2014.03.001_bib117","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","author":"Digitalis Investigation Group","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib118","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.iccl.2014.03.001_bib119","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib120","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2014.03.001_bib121","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization\u00a0therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N\u00a0Engl J Med"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745814000182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745814000182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T03:16:40Z","timestamp":1716866200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745814000182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":121,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S2211745814000182"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2014.03.001","relation":{},"ISSN":["2211-7458"],"issn-type":[{"value":"2211-7458","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implications of Kidney Disease in the Cardiac Patient","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2014.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}